» Articles » PMID: 16707194

ESPEN Guidelines on Enteral Nutrition: Liver Disease

Overview
Journal Clin Nutr
Publisher Elsevier
Date 2006 May 19
PMID 16707194
Citations 148
Authors
Affiliations
Soon will be listed here.
Abstract

Enteral nutrition (EN) by means of oral nutritional supplements (ONS) and tube feeding (TF) offers the possibility to increase or to insure nutrient intake in case of insufficient oral food intake. The present guideline is intended to give evidence-based recommendations for the use of ONS and TF in patients with liver disease (LD). It was developed by an interdisciplinary expert group in accordance with officially accepted standards and is based on all relevant publications since 1985. The guideline was discussed and accepted in a consensus conference. EN by means of ONS is recommended for patients with chronic LD in whom undernutrition is very common. ONS improve nutritional status and survival in severely malnourished patients with alcoholic hepatitis. In patients with cirrhosis, TF improves nutritional status and liver function, reduces the rate of complications and prolongs survival. TF commenced early after liver transplantation can reduce complication rate and cost and is preferable to parenteral nutrition. In acute liver failure TF is feasible and used in the majority of patients.

Citing Articles

Expert consensus on perioperative management of liver transplantation in adults with acute-on-chronic liver failure.

Liver Res. 2025; 5(2):37-44.

PMID: 39959341 PMC: 11791809. DOI: 10.1016/j.livres.2021.03.002.


Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease.

Hao X, Song H, Su X, Li J, Ye Y, Wang C Ann Med. 2025; 57(1):2464223.

PMID: 39943720 PMC: 11827040. DOI: 10.1080/07853890.2025.2464223.


Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis.

Diaz-Ruiz R, Poca M, Roman E, Panadero-Gomez R, Cuyas B, Banares I Nutrients. 2025; 17(2.

PMID: 39861356 PMC: 11768058. DOI: 10.3390/nu17020226.


Advances in the management of alcohol-associated liver disease.

Anouti A, Kerr T, Mitchell M, Cotter T Gastroenterol Rep (Oxf). 2024; 12:goae097.

PMID: 39502523 PMC: 11537353. DOI: 10.1093/gastro/goae097.


Current Pharmacotherapy and Nutrition Therapy of Alcohol-Associated Liver Disease.

Hardesty J, McClain C Clin Liver Dis. 2024; 28(4):731-745.

PMID: 39362718 PMC: 11529778. DOI: 10.1016/j.cld.2024.06.018.